Los Angeles, California – May 18, 2023 – Physicians Cannabinoid Council (PCC), a consortium of physicians and specialists in the fields of family medicine, internal medicine, rheumatology, pain management, endocrinology, and nephrology, has recognized Hempeutics Pharmacy for becoming the first pharmacy to successfully pass the “Physicians Quality Verified” certification program. In an effort to lead the fight against unregulated CBD products, the PCCouncil launched their product certification program for brands to obtain their Physicians Quality Verified Seal. These programs assist the industry in the furthering of self-regulation, which is necessary to deliver quality and effective products to the public. To successfully pass the program, the entity in question must meet the following criteria: 

• Good Manufacturing Practice

• Labeling and Potency accuracy

• Quality Tested and Verified by PCC

...

Many have been turning to CBD for relief when looking for relief from anxiety, insomnia, or chronic pain. The CBD market has been growing by leaps and bounds in recent years, with  20% of Americans using CBD in some form. 

However, with the overwhelming popularity of CBD products has come the issue of businesses capitalizing on that popularity by releasing low-quality CBD products that can be ineffective or even dangerous. Moreover, the federal government currently offers no regulation for CBD products, meaning these sub-par products can easily end up on store shelves.

The Physicians Cannabinoid Council has emerged to combat the issue of unregulated CBD products with its recently launched certification program and Physicians Quality Verified Seal. These programs bring the CBD industry closer to the self-regulation necessary to deliver the best, most effective products to consumers. 

Physicians Cannabinoid Council Receives Award for Best Consumer Safety-Focused CBD Organization

We e...

Have you noted that we use the name Physicians Cannabinoid Council frequently? It is to be more inclusive of all the important cannabinoids found in the cannabaceae family of plants that include hemp and hops, and more. What? you mean there are other compounds than CBD?  Yes and the recent interest in CBGA (cannabigerolic acid), a unique and rare compound found in the cannabis plant, which is quite exciting for many.

CBGA is a precursor to several other well-known cannabinoids such as THC, CBD, CBC, and CBG and is considered the “mother of all cannabinoids”.

Despite its previously limited presence in the plant, experts are now breeding strains with higher levels of CBGA. The newly found interest is due to its potential as a natural inhibitor and its ability to expedite early cell death. The importance of that is the fact that failure of cells to die, or cells dying when they shouldn’t, can lead to or exacerbate many diseases.

According to a study published in Science Direct in June ...

The CBD market is booming and on a path toward remarkable growth over the next few years. In 2021, the market was valued at $5.18 billion, and experts estimate that number is due to grow at a rate of 16.8% from 2022 to 2030. 

CBD is a popular go-to for consumers in hope of finding relief for anxiety relief, pain relief, and better sleep. However, with popularity often comes the problem of less-than-quality products hitting shelves. Since the federal government does not regulate CBD, the door is left open for unscrupulous companies to introduce low-quality products to the market, which can often cause side effects or contain toxic chemicals. 

Improving knowledge and quality 

In the past, it was up to the consumer to research and determine whether the CBD they were purchasing was a quality product. Now, a group of physicians and specialists in family medicine, internal medicine, rheumatology, pain management, endocrinology, and nephrology has been assembled with the specific goal of p...

The FDA has issued a letter warning seven CBD companies to refrain from falsely claiming their products can help treat or prevent coronavirus infections.

According to the FDA, a total of seven companies are accused of “using research studies to claim or imply misleadingly that their CBD products” can help when it comes to COVID-19.

Joint warning letters were issued by the Federal Trade Commission (FTC) to these businesses: 

• Cureganics
• Heaven’s Organics LLC
• Functional Remedies LLC
• Greenway Herbal Products LLC
• CBD Social
• UPSY LLC
• Nature’s Highway 

Nature’s Highway is accused of sharing an online graphic titled “CBD + COVID-19 = BREATHE EASIER?” and writing “several recent studies suggest that CBD, with other phytochemicals found in hemp, might open up your lungs, help fight inflammation there, and kick your immune system into a higher gear.”

“The FDA has not approved or authorized any drug containing CBD for the treatment or prevention of COVID-19. We request that you ta...

Why should patients and consumers care more about data than reviews? Let’s get into it. Have you ever had a bad experience with a product, service, or establishment that motivated you enough to leave a… very detailed review? Sharing your less-than-ideal experience? I’m sure you know what I mean. What about the other extreme? Did you have an amazing experience with a product, service, or establishment and thought you had to let the world know how awesome your experience was? What would the rest of us do without these individuals giving us the good and the bad for all things we are interested in? Clearly, reviews are a significant factor in our purchasing decisions. If not, sites like Yelp and Amazon wouldn’t be as popular as they are.

When it comes to health and wellness-related products though, patients and consumers deserve better than subjective reviews into the good and bad extremes.

And by better, I really mean more. More clarity. More insight. More consistency. More transparen...

 PHYSICIANS CANNABINOID COUNCIL JOINS MOREBETTER AND UNIVERSITY OF MICHIGAN TO
RECRUIT CALIFORNIA RESIDENTS FOR A FIRST OF ITS KIND STUDY ON THE EFFICACY OF
UNIQUE CANNABINOID FORMULATIONS AND DOSING FOR SPECIFIC TYPES OF CHRONIC PAIN.

Los Angeles, California: The Physicians Cannabinoid Council, an organization with over 35 renown healthcare professionals as active members, announce their support of a first of its kind cannabinoid research study led by researchers at the University of Michigan and MoreBetter (Releaf App). The study will lay the groundwork for understanding what formulations and dosing regimens could be most efficacious for Fibromyalgia, Rheumatoid Arthritis, and Osteoarthritis.The biggest challenge for healthcare professionals with cannabinoid-based medicine is the lack of evidence in product formulation and dosing. Most published studies only evaluate if cannabis or CBD is effective. This leaves practitioners and patients left to guess and begin a trial-and-error proce...

Over the past three years, CBD and other cannabinoid products such as CBG, CBN, or other compounds of the hemp plant have flooded the market. From corner stores to large retailers, carrying CBD products has become the new trend. Sales have exploded, and the stigma surrounding the plant is slowly vanishing, hence it has become more and more common for people to discuss openly their self-medication success using CBD products.

When the well-known Dr. Dung Trinh, MD conducts his educational series at senior facilities, he often asks the question: How many of you take CBD products? Only three years ago, ten to fifteen out of one hundred people would raise their hands. Today, nearly all of them answer yes. CBD products are used by consumers to help promote better sleep, as part of a pain management routine, or to help reduce inflammation. 

SHOULD WE BE EXCITED?

This new phenomenon is both great and worrisome. It is good in the sense that there are a lot of benefits related to this co...